Indications
Treatment of patients with primary pulmonary hypertension, classified as New York Heart Association functional class III, to improve exercise capacity and symptoms.
Composition
- Active substance
- iloprost
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Ventavis
- Active substance
- iloprost
- ATC code
- B01AC11
- Therapeutic area
- Hypertension, Pulmonary
- Marketing authorisation holder
- Bayer AG
- Status
- Authorised
- EU authorisation
- 15 Sept 2003